StonvexLoading…
StonvexCore line items from DNOW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.18B | $2.82B | $1.86B | $1.23B |
Operating Income | $-50.00M | $-93.00M | $95.00M | $62.00M |
Net Income | $-44.00M | $-89.00M | $72.00M | $47.00M |
EPS (Diluted) | $-0.24 | $-0.76 | $0.66 | $0.43 |
Total Assets | $3.93B | $3.92B | $1.66B | $1.66B |
Total Liabilities | $1.78B | $1.69B | $475.00M | $500.00M |
Cash & Equivalents | $116.00M | $164.00M | $266.00M | $232.00M |
Free Cash Flow OCF − CapEx | $-103.00M | $134.00M | $58.00M | $19.00M |
Shares Outstanding | 182.67M | 186.13M | 105.01M | 105.01M |